Compare drug alternatives
Trijardy XR® Alternatives
Trijardy XR®(Empagliflozin, Linagliptin, Metformin Hydrochloride) | Soliqua®(Insulin Glargine And Lixisenatide) |
|---|---|
Prescription Only | Prescription Only |
| Dosage & Administration | Dosage & Administration comparison data |
Administration | |
Oral . Learn more. | |
Dosing | |
The maximum recommended dose of TRIJARDY XR is 25 mg empagliflozin, 5 mg linagliptin and 2000 mg metformin HCl. Take once daily with a meal in the morning. Swallow whole; do not split, crush, dissolve, or chew.. Learn more. | |
Latin Shorthand | |
Max dose TRIJARDY XR: 25 mg empagliflozin, 5 mg linagliptin, 2000 mg metformin HCl. Take 1x daily with AM meal. Swallow whole; no splitting, crushing, dissolving, or chewing.. Learn more. | |
| Financial Assistance | Financial Assistance comparison data |
Out-Of-Pocket Costs With Copay Card | |
$10. Learn more. | |
Annual Cap | |
$175 per month. Learn more. | |
Assistance Expiration | |
12/31/23. Learn more. | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
| Physician Advisory | Physician Advisory comparison data |
Adverse Reactions | |
Most common adverse reactions (5% or greater incidence) were upper
respiratory tract infection, urinary tract infection, nasopharyngitis, diarrhea,
constipation, headache, and gastroenteritis. . Learn more. | The most common adverse reactions, reported in ≥5% of patients treated with
SOLIQUA 100/33 include hypoglycemia, nausea, nasopharyngitis, diarrhea, upper
respiratory tract infection, and headache.. Learn more. |
Mechanism of Actions (MoA) | |
SGLT2 Inhibitors. Learn more. | |
Special Populations | |